ArticleMaterials (Basel, Switzerland)2025
Tunable Superconductivity in BSCCO via GaP Quantum Dots.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The enhancement of superconducting properties of high-temperature copper-oxide superconductors like B(P)SCCO remains a hot research topic in the field of superconducting materials. This study introduces GaP quantum dots (QDs) as a heterophase, leveraging their electroluminescent properties to enhance the superconductivity of B(P)SCCO. Experimental results demonstrate that the electroluminescence generated by GaP quantum dots (QDs) under an applied electric field induces tunable superconducting enhancement of B(P)SCCO. A reproducible trend of enhancement in the critical transition temperature (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.